Company news

IDEXX Laboratories, Inc. news in 2026

IDEXX Laboratories, Inc.'s news releases, calls and decks from 2026, newest first.

View company

IDEXX Laboratories Announces Third Quarter Results

November 2, 2026

IDEXX Laboratories to Release 2026 Third Quarter Financial Results

October 1, 2026

IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection

September 17, 2026

IDEXX Laboratories Acquires CoVetAI to Advance Veterinary Workflow Intelligence

September 16, 2026

IDEXX Laboratories to Participate in Morgan Stanley 24th Annual Global Healthcare Conference

August 31, 2026

IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test

August 11, 2026

Earnings snapshot Q2 2026

August 4, 2026

IDEXX Releases 2025 Corporate Responsibility Report, Highlighting Progress Against Its Goals

July 28, 2026

IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection

May 26, 2026

IDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry Profiles

May 18, 2026

IDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor Day

May 14, 2026

Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q)

May 5, 2026

Earnings snapshot Q1 2026

May 5, 2026

Idexx: Q1 Earnings Snapshot

May 5, 2026

University of New England launches new Institute of Public and Planetary Health in honor of philanthropist and IDEXX Founder David Evans Shaw

April 27, 2026

IDEXX Laboratories to Release 2026 First Quarter Financial Results

April 7, 2026

IDEXX Announces UK Availability of Cancer Dx Panel for Early Detection of Canine Lymphoma

March 31, 2026

Raymond James Institutional Investors Conference Presentation

March 2, 2026

IDEXX Laboratories to Present at Two Institutional Investor Conferences

February 12, 2026

IDEXX Laboratories Announces Fourth Quarter and Full Year 2025 Results

February 2, 2026

Lowest-Dose Radiography Meets Next-Level Imaging: IDEXX Launches ImageVue DR50 Plus

January 15, 2026

IDEXX Advances the Future of Veterinary Cancer Care with Comprehensive Mast Cell Tumor Testing for Dogs

January 14, 2026

IDEXX Announces CEO Succession

January 13, 2026

IDEXX Laboratories to Release 2025 Fourth Quarter and Full Year Financial Results

January 9, 2026

Calls in 2026

Decks in 2026